STAT+: Pharmalittle: EMA official says link exists between AstraZeneca Covid-19 shot and rare blood clots; Catalent to boost Moderna vaccine production

Top of the morning, and a fine one it is. Clear blue skies and a shiny sun are enveloping the comfy Pharmalot campus, where the short person is hunched over a laptop and the spirited official mascot is chasing varmints. As for us, we are firing up the trusty coffee kettle to brew more cups of stimulation. For those who track this sort of thing, our choice today is maple bourbon. Meanwhile, we have assembled a few items of interest for you. We hope your day is productive and you conquer the world. And of course, do stay in touch. We appreciate your juicy tips and insights. …

A European Medicines Agency official told an Italian news site that there is a link between the AstraZeneca (AZN) Covid-19 vaccine and blood clots, Agence France Presse writes. Persistent questions on whether rare but serious blood clots among those getting the shot are more frequent than in the general population have undermined confidence in the beleaguered vaccine. After several countries suspended use of the vaccine, the EMA said the benefits outweigh the risks and it should remain in use, but an updated assessment is expected this week.

Continue to STAT+ to read the full story…

STAT+: Pharmalittle: EMA official says link exists between AstraZeneca Covid-19 shot and rare blood clots; Catalent to boost Moderna vaccine production

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top